To assess the safety and efficacy of IV ibuprofen in older adults, researchers conducted a post hoc subgroup analysis with data from 4 prospective clinical studies.

ND0612 is an investigational drug-device therapy that provides a 24-hour continuous subcutaneous infusion of levodopa/carbidopa solution. The Food and Drug Administration (FDA) has accepted for review ...

The trained AI model correctly detected 98 and 100% of body parts and eczema areas, respectively; across 220 test images. HealthDay News — An artificial intelligence (AI) 3-Item Severity (3IS) score ...

In a recent interview on NBC News’ "Meet the Press," Murthy said Congress has failed to act on what he described as a growing crisis.

“The FDA’s decision to grant Fast Track designation for TEV-53408, an investigational anti-IL-15 antibody therapy, reflects the promising nature of the treatment and the urgent unmet need of people ...

Findings seen for patients with extensive-stage small cell lung cancer, following standard induction therapy.

The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for sibeprenlimab for the treatment of immunoglobulin A nephropathy (IgAN) in adults.